Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TIPRANAVIR Cause Dyslipidaemia? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Dyslipidaemia have been filed in association with TIPRANAVIR (Aptivus). This represents 2.0% of all adverse event reports for TIPRANAVIR.

8
Reports of Dyslipidaemia with TIPRANAVIR
2.0%
of all TIPRANAVIR reports
0
Deaths
7
Hospitalizations

How Dangerous Is Dyslipidaemia From TIPRANAVIR?

Of the 8 reports, 7 (87.5%) required hospitalization.

Is Dyslipidaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TIPRANAVIR. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does TIPRANAVIR Cause?

Cholelithiasis (218) Schizophrenia (217) Nausea (216) Pneumonia (216) Vomiting (216) Hypomania (151) Hepatotoxicity (148) Psychotic disorder (148) Blood bilirubin increased (147) Condition aggravated (147)

What Other Drugs Cause Dyslipidaemia?

OLANZAPINE (230) ROSUVASTATIN (206) ARIPIPRAZOLE (185) METHOTREXATE (175) QUETIAPINE (161) ATORVASTATIN (155) RISPERIDONE (154) METFORMIN (151) TACROLIMUS (149) ZIPRASIDONE (149)

Which TIPRANAVIR Alternatives Have Lower Dyslipidaemia Risk?

TIPRANAVIR vs TIRBANIBULIN TIPRANAVIR vs TIROFIBAN TIPRANAVIR vs TIRZEPATIDE TIPRANAVIR vs TISAGENLECLEUCEL TIPRANAVIR vs TISLELIZUMAB

Related Pages

TIPRANAVIR Full Profile All Dyslipidaemia Reports All Drugs Causing Dyslipidaemia TIPRANAVIR Demographics